Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome.
Masharani
Umesh
U
Department of Medicine, University of California, San Francisco, Diabetes Center, San Francisco, California 94143 , USA. umeshm@medicine.ucsf.edu
Gjerde
Christine
C
Evans
Joseph L
JL
Youngren
Jack F
JF
Goldfine
Ira D
ID
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D015444:Exercise; D005260:Female; D015309:Glucose Clamp Technique / Q000379:methods; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood; D007328:Insulin / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000097:blood / Q000145:classification; D008597:Menstrual Cycle / Q000187:drug effects; D018384:Oxidative Stress; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000188:drug therapy*; D013851:Thinness / Q000097:blood; D008063:Thioctic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D003692:Delayed-Action Preparations; D007328:Insulin; D008077:Lipoproteins, LDL; D014280:Triglycerides; D008063:Thioctic Acid; D002784:Cholesterol